Modulation of Human CYP19A1 Activity by Mutant NADPH P450 Oxidoreductase
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Mutations in NADPH P450 oxidoreductase (POR) cause a broad spectrum of human disease with abnormalities in steroidogenesis. We have studied the impact of P450 reductase mutations on the activity of CYP19A1. POR supported CYP19A1 activity with a calculated Km of 126 nm for androstenedione and a Vmax of 1.7 pmol/min. Mutations R457H and V492E located in the FAD domain of POR that disrupt electron transfer caused a complete loss of CYP19A1 activity. The A287P mutation of POR decreased the activities of CYP17A1 by 60-80% but had normal CYP19A1 activity. Molecular modeling and protein docking studies suggested that A287P is involved in the interaction of POR:CYP17A1 but not in the POR:CYP19A1 interaction. Mutations C569Y and V608F in the NADPH binding domain of POR had 49 and 28% of activity of CYP19A1 compared with normal reductase and were more sensitive to the amount of NADPH available for supporting CYP19A1 activity. Substitution of NADH for NADPH had a higher impact on C569Y and V608F mutants of POR. Similar effects were obtained at low/high (5.5/8.5) pH, but using octanol to limit the flux of electrons from POR to CYP19A1 inhibited activity supported by all variants. High molar ratios of KCl also reduced the CYP19A1 supporting activities of C569Y and V608F mutants of POR to a greater extent compared to normal POR and A287P mutant. Because POR supports many P450s involved in steroidogenesis, bone formation, and drug metabolism, variations in the effects of POR mutations on specific enzyme activities may explain the broad clinical spectrum of POR deficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, a previous in vitro study found that p.A287P does not impair CYP19A1 activity, but p.R457H abolishes aromatase activity (29).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [29]
In the citing paper
“Together, these findings strongly suggest that p.R457H is a common pathogenic variant in East Asian populations.”
From Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review (2026) · cites this paper as [68]
In the citing paper
“Not surprisingly, the R457H mutant cannot support P450aro activity in vitro, whereas the A287P mutant retains full activity with P450aro (328).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [328]
Citations
Cites
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150181505 · Cited by 11,241
Multiple sequence alignment with the Clustal series of programs
Chenna, R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg500 · Cited by 4,875
Stereochemistry of polypeptide chain configurations
Ramachandran, G. N., Ramakrishnan, C., & Sasisekharan, V. (1963) · Journal of Molecular Biology · doi:10.1016/s0022-2836(63)80023-6 · Cited by 3,554
WHAT IF: A molecular modeling and drug design program
Vriend, G. (1990) · Journal of Molecular Graphics · doi:10.1016/0263-7855(90)80070-v · Cited by 3,469
[20] VERIFY3D: Assessment of protein models with three-dimensional profiles
Eisenberg, D., Lüthy, R., & Bowie, J. U. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77022-8 · Cited by 2,192
Hooft, R. W. W., Vriend, G., Sander, C., & Abola, E. E. (1996) · Nature · doi:10.1038/381272a0 · Cited by 2,173
Stereochemical quality of protein structure coordinates
Morris, A. L., MacArthur, M. W., Hutchinson, E. G., & Thornton, J. M. (1992) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340120407 · Cited by 1,553
Phillips, A. H., & Langdon, R. G. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)73803-4 · Cited by 1,427
Molecular biology of steroid hormone synthesis
MILLER, W. L. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-3-295 · Cited by 1,397
Cited by
Items 101–132 of 132
Flück, C. E., & Pandey, A. V. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_10-1 · Cited by 7
Self-citationJin, Y., Chen, M., Penning, T. M., & Miller, W. L. (2015) · Biochemical Journal · doi:10.1042/bj20141410 · Cited by 6
“Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase.”
BackgroundReisch, N., Auchus, R. J., Shackleton, C. H. L., Hanley, N. A., & Arlt, W. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007695117 · Cited by 6
Finding New Molecular Targets of Familiar Natural Products Using In Silico Target PredictionPreprint
Mayr, F., Möller, G., Garscha, U., Fischer, J., Castaño, P. R., Inderbinen, S. G., Temml, V., Waltenberger, B., Schwaiger, S., Hartmann, R. W., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.01.181859 · Cited by 6
Self-citationFlück, C. E. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8002-1_1 · Cited by 5
Self-citationEditorial: Role of Protein-Protein Interactions in Metabolism: Genetics, Structure, Function
Pandey, A. V., Henderson, C. J., Ishii, Y., Kranendonk, M., Backes, W. L., & Zanger, U. M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00881 · Cited by 5
“Using CYP19A1 (aromatase) (Pandey et al., 2007) for steroid metabolism and CYP3A4 for drug metabolism (Flück et al.”
BackgroundMethodSelf-citationFinding New Molecular Targets of Familiar Natural Products Using In Silico Target PredictionPreprint
Mayr, F., Möller, G., Garscha, U., Fischer, J., Castaño, P. R., Inderbinen, S. G., Temml, V., Waltenberger, B., Schwaiger, S., Hartmann, R. W., et al. (2020) · Preprints.org · doi:10.20944/preprints202007.0495.v1 · Cited by 4
Self-citationAhmed, S., Zhou, J., Zhou, Z. M., & Chen, S.-Q. (2018) · Genes · doi:10.3390/genes9100514 · Cited by 5
“The functional effects of various CYPOR allelic variants are CYP enzyme and substrate dependent [23,24].”
BackgroundVelazquez, M. N. R., Noebauer, M., & Pandey, A. V. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.16.504152 · Cited by 4
Self-citationAgrawal, V., & Miller, W. L. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-321-3_19 · Cited by 4
Parween, S., Nardo, G. D., Baj, F., Zhang, C., Gilardi, G., & Pandey, A. V. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/664839 · Cited by 3
“CYP19A1 activity of proteins was monitored by the tritiated water release assay based on an earlier method described by Lephart and Simpson [78] with slight modifications that have been described previously using an assay system containing lipids, POR and CYP19A1 [64, 68].”
BackgroundMethodSelf-citationZhang, D., 姚凤霞, Luo, M., Deng, S., & Tian, Q. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01878-8 · Cited by 5
A Novel POR G88S Mutation Causes Severe PORD and Establishes a Critical Pharmacogenomic Risk Profile
Velazquez, M. N. R., Dacal, J. L., Jørgensen, F. S., Sanguineti, N., Sharma, K., Marino, R. M., Garrido, N. P., Vaiani, E., Ramírez, P., Scaglia, P. A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf630 · Cited by 4
Self-citationFunctional analysis of AccCPR in Apis cerana cerana under pesticide and heavy metal stress
Li, L., Yang, C., Du, J., Liu, Z., Wang, Y., Wang, H., Chi, X., & Xu, B. (2025) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2025.106296 · Cited by 2
P450 oxidoreductase deficiency
Flück, C. E., Velazquez, M. N. R., & Pandey, A. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00012-5 · Cited by 4
Self-citationVelazquez, M. N. R., Parween, S., Udhane, S. S., & Pandey, A. V. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/640540 · Cited by 2
“We have been studying the variations in human POR genes since its link to disorders of steroid biosynthesis was discovered in 2004 [15,16,17,22,23,24,25,26,27,41,42,43].”
BackgroundMethodInfluentialSelf-citationZhen, C., Wu, R., Tan, Y., Zhang, A., & Zhang, L. (2024) · Bulletin of Entomological Research · doi:10.1017/s0007485324000488 · Cited by 2
Flück, C. E., Yakubu, J. Y., & Pandey, A. V. (2026) · Endocrinology · doi:10.1007/978-3-319-29456-8_10-2
Self-citationManzoor, S., Hofer, T. S., & Moin, S. T. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00103 · Cited by 1
Menassa, R. (2009) · theses.fr (ABES) · doi:10.70675/b3e39fd0z238az4865z8447z7bdf24b846fb · Cited by 1
Zhang, C., Zhao, Z., Du, Y., Huang, Q., Liu, Y., Fu, G., & Xu, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1791297
“This high prevalence was later corroborated in a nationwide Japanese study by Yatsuga et al. (68).”
Gomes, L. G. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-09122009-152831
Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase
Haskins, A., & Arlt, W. (2015)
Gonzalo, I. V. (2016) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · doi:10.6035/14114.2016.84191
El-Sherbeni, A. A. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3sf2mq22
Computational prediction of damage associated non synonymous SNPs of CYP17A1 and CYP19A1 gene
Bhatnager, R., Kaur, R., & Dang, A. S. (2017) · International Journal of Trend in Scientific Research and Development · doi:10.31142/ijtsrd3581
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00004-8
Human P450 oxidoreductase deficiency
Pandey, A. V., Barata, I. S., & Flück, C. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00259-4
Self-citationDisorders of the Adrenal Cortex in the Fetus and Neonate
Flück, C. E., du Toit, T., & Miller, W. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00035-1
Self-citationAromatase as a Central Node in Astrocyte Health and Homeostasis
Faddetta, M., Borda, M. G., & Barreto, G. E. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05609-7 · Cited by 1
“Aromatase, encoded by the CYP19A1 gene, is a cytochrome P450 that converts androgens such as testosterone and androstenedione into estrogens, notably 17β-estradiol (E2) and estrone (E1) [12–14].”
Yang, H.-J., Fu, J.-Y., Yi, Z.-W., Han, C.-Y., Zhao, S.-Y., Zhu, X.-F., Liu, H.-R., & Chen, X.-G. (2026) · Parasites & Vectors · doi:10.1186/s13071-026-07593-w
“Similarly, the hydrophobic N-terminal membrane anchor ensures proper spatial positioning between CPR and P450, which is essential for participation in the P450 catalytic cycle and normal enzymatic function [50, 51].”
Vetriselvan, Y., Murugan, M., Samantaray, M., Ganesh, I., Jayakumar, S., Samuel, M., Singh, S., Shanmugam, D., & Ravikumar, S. (2026) · Reproductive Sciences · doi:10.1007/s43032-026-02242-0
Metadata
- Authors
- Pandey, A. V., Kempná, P., Hofer, G., Mullis, P. E., & Flück, C. E.
- Affiliations
- University of Bern (CH)
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-10
- Volume
- 21
- Issue
- 10
- Pages
- 2579-2595
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2045490130
- Semantic Scholar
- 250e545e90127942a775447e5f4c518fe09840aa
- Cited by
- 132
- References
- 90
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 6 · 2020: 8 · 2019: 13 · 2018: 4 · 2017: 9 · 2016: 9 · 2015: 9 · 2014: 6 · 2013: 7 · 2012: 8
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- Funders
- Sichuan University of Science and Engineering
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- CYP19A1, aromatase, steroidogenesis, FAD domain, electron transfer, NADH, pH effect, 1-octanol, enzyme kinetics
- MeSH terms
- Aromatase, Binding Sites, Electron Transport, Humans, Hydrogen-Ion Concentration, Models, Molecular, Mutation, NADPH-Ferrihemoprotein Reductase, Potassium Chloride, Steroid 17-alpha-Hydroxylase, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.